These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6683483)

  • 1. [Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or cddp in combination with adriamycin (ADM)].
    Nishimura H; Yamada T; Hagio Y; Inoue T; Tsunawaki A; Yakushiji M; Kato T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):938-43. PubMed ID: 6683483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
    Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
    Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase in CDDP therapeutic index by lower concentration and longer infusion time--home chemotherapy for ovarian cancer].
    Chen JT; Tatsuki Y; Hirai Y; Hasumi K
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):265-70. PubMed ID: 8434965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Diamminedichloroplatinum(II) therapy for advanced ovarian cancer.
    Pesando JM; Come SE; Stark J; Parker LM; Griffiths CT; Canellos GP
    Cancer Treat Rep; 1980; 64(10-11):1147-8. PubMed ID: 7193089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
    Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B
    Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum in combination with cyclophosphamide. An E.C.O.G. pilot study.
    Israel L; Aguilera J; Breau JL
    Am J Clin Oncol; 1983 Feb; 6(1):85-9. PubMed ID: 6682285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of platinum in mono- anc combination therapy in a prospective multicenter study].
    Krafft W
    Zentralbl Gynakol; 1989; 111(14):938-46. PubMed ID: 2678834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
    Covens A; Blessing J; Bender D; Mannel R; Morgan M;
    Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisplatin alone or in combination with adriamycin in the treatment of patients with head and neck cancer relapsed after radiotherapy and/or surgery.
    Villar A; Farrus B; Giner P; Sedano E; Serradell J; de Caralt M
    Rev Esp Oncol; 1981; 28(3):395-412. PubMed ID: 6892263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy.
    Vogl SE; Pagano M; Kaplan BH; Einhorn N; Arseneau J; Moukhtar M; Greenwald E
    Obstet Gynecol; 1980 Nov; 56(5):635-40. PubMed ID: 6776457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II.
    Mäenpää J
    Obstet Gynecol; 1985 Nov; 66(5):714-8. PubMed ID: 3903584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer.
    Goldberg JM; Piver MS; Hempling RE; Recio FO
    Gynecol Oncol; 1996 Dec; 63(3):312-7. PubMed ID: 8946864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A; Carnino F; Chiara S; Brunetti I; Tanganelli L; Romanini A; Bruzzone M; Conte PF
    Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of metastatic urothelial carcinoma].
    Kihara K; Sakuramoto T; Washizuka M; Kawai T; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.
    Gorumlu G; Kucukzeybek Y; Kemal-Gul M; Karaca B; Cosan-Terek M; Karabulut B; Sanli UA; Akman L; Ozsaran A; Dikmen Y; Uslu R
    J BUON; 2008; 13(3):349-52. PubMed ID: 18979548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.